Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study

Lung cancer is the most often diagnosed cancer and the main cause of cancer deaths in the world compared with other tumor entities. To date, the only screening method for high‐risk lung cancer patients is low‐dosed computed tomography which still suffers from high false‐positive rates and overdiagno...

詳細記述

書誌詳細

出版年:	Molecular Oncology
主要な著者:	Lucija Ačkar, Swaantje Casjens, Antje Andreas, Irina Raiko, Thomas Brüning, Maria Geffken, Sven Peine, Jens Kollmeier, Georg Johnen, Kai Bartkowiak, Daniel Gilbert Weber, Klaus Pantel
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2021-11-01
主題:	biomarker cancer CYR61 liquid biopsy lung cancer plasma
オンライン･アクセス:	https://doi.org/10.1002/1878-0261.13099